ENTITY

Newlink Genetics (NLNK US)

Health Care • United States

NewLink Genetics Corporation as a biopharmaceutical company. The Company discovers, develops, and commercializes novel immuno-oncology products to helps cancer patients. NewLink Genetics operates in the United States.

Refresh

Focused

No publications yet

There aren’t any sponsored reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00